BioSpace News Archive

Pharm Country

European Medicines Agency Adopts Positive Opinion for KEYTRUDA® (pembrolizumab) Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer

KEYTRUDA Combination Improved Overall Survival Compared with Pemetrexed and Platinum Chemotherapy Alone in Pivotal Phase 3 Trial

July 30, 2018
·
27 min read
Business

OrangeTwist Aesthetic Treatment Boutique Adds Revolutionary ALASTIN Skincare® Products To Cutting-Edge Aesthetic Practices

Announced with this new partnership is the addition of ALASTIN Skincare’s award-winning line of products to OrangeTwist’s family of carefully curated medical-grade skincare solutions.

July 30, 2018
·
4 min read
Lone Star Bio

Castle Biosciences Presents Data Demonstrating the DecisionDx-Melanoma Test Improved AJCC-Based Risk Prediction for Melanoma Recurrence and Metastasis

Test demonstrated high technical reliability in over 17,000 clinical orders

July 30, 2018
·
5 min read
Drug Development

Presbyopia Therapies Announces Primary Safety and Efficacy Endpoints met in a Phase IIb study of its Topical PRX Ophthalmic Solution for the Treatment of Presbyopia

Presbyopia Therapies, LLC announced that the primary efficacy and safety endpoints have been met in a Phase IIb study of its PRX ophthalmic solution.

July 30, 2018
·
3 min read
Drug Development

Appili Therapeutics Completes Phase 1 Study for ATI-1501, Its Taste-Masked Oral Metronidazole Suspension, Demonstrating Significant Improvements in Taste and Palatability

New Antibiotic Formulation Designed to Treat Parasitic and Anaerobic Bacterial Infections; Appili Will Use Study Data as Basis for NDA Filing

July 30, 2018
·
5 min read
Business

OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory

OncoSec Medical Incorporated announced the appointment of Robert W. Ashworth, Ph.D. as Vice President, Regulatory.

July 30, 2018
·
4 min read
Policy

Motus GI Strengthens IP Portfolio with Issuance of Japanese Patent for the Pure-Vu® System

Expansion of global IP portfolio continues to lay foundation for future growth opportunities in key markets outside the United States

July 30, 2018
·
4 min read
Business

HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with Takeda

Global pharmaceutical leader selects innovative single-B-cell technology to generate breakthrough therapies

July 30, 2018
·
2 min read
Business

Emmaus Life Sciences Partners with DMS Pharmaceutical Group to Provide Endari™ (L-glutamine oral powder) to Military Personnel and Beneficiaries for Treatment of Sickle Cell Disease

Emmaus Life Sciences (Emmaus) announces it has entered into a distribution agreement with DMS Pharmaceutical Group (DMS).

July 30, 2018
·
4 min read
Business

ABL Bio and I-Mab Biopharma Announce Global Collaboration on Innovative Bispecific Antibodies

I-Mab and ABL Bio will collaborate on three novel Bispecific Antibodies (BsAbs) while ABL Bio is licensing additional I-Mab antibody sequences for development using ABL Bio’s BsAb platform.

July 30, 2018
·
4 min read